Baxter International Inc. (BAX) develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis and additional dialysis therapies and services. It also provides renal replacement therapies and other organ support therapies focused in the intensive care unit. On the other hand, Becton Dickinson and Company (BDX) develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public worldwide.
The COVID-19 pandemic-led awareness about health and hygiene has driven the demand for medical equipment & supplies across the world. In addition, with the rising prevalence of chronic diseases and the geriatric population, the need for healthcare products is further increasing. Moreover, increased investments, rising hospital-acquired infections, and a growing shift to home-based settings will likely boost the medical equipment & supply market’s growth in the upcoming years. According to a report by Valuates Reports, the global medical supplies market is expected to grow at a 7.1% CAGR from 2022 to 2028. Therefore, both BAX and BDX should benefit.
